Variceal Bleeding in Patients with Initation of Sofosbuvir and Ribavirin – Case Reports

Main Article Content

Sadiq Memon
Madiha Zaki
Shahzad Ali Jiskani

Abstract

Abstract: Sofosbuvir is an oral nucleoside analogue and potent inhibitor of the Hepatitis C virus (HCV) RNA polymerase that is used in combination with other antiviral agents to treat chronic Hepatitis C Nevertheless, and for unknown reasons, successful antiviral therapy of Hepatitis C with Sofosbuvir and other direct acting agents in patients with cirrhosis is occasionally complicated by hepatic decompensation. Here we describe 2 case report of upper gi bleed at initial days of treatment with Sofosbuvir and Ribavirin.

Article Details

How to Cite
1.
Memon S, Zaki M, Jiskani SA. Variceal Bleeding in Patients with Initation of Sofosbuvir and Ribavirin – Case Reports. Nat J Health Sci [Internet]. 2021Jul.26 [cited 2024Jul.19];5(4):175-6. Available from: https://ojs.njhsciences.com/index.php/njhs/article/view/185
Section
Case Report